Acessibilidade / Reportar erro

What is the angiography error when defining myocardial ischemia during percutaneous coronary interventions?

Abstracts

BACKGROUND: The angiography has been used as a reference standard to define coronary artery disease (CAD), although its limitations are well-known. The significance of the myocardial fractional flow reserve (FFR) in the assessment of CAD is well established. OBJECTIVE: The aim of this study was to evaluate the accuracy of angiography when defining ischemic lesions and its correlation with FFR. METHODS: Two hundred and fifty consecutive patients (471 arteries) were included in this study. All stenoses > 50% at the angiography visual estimate (AVE) were assessed by FFR measurements. When FFR was < 0.75, stenting was performed; when FFR was > 0.75, no interventional treatment was carried out. Offline quantitative coronary angiography (QCA) was performed in all stenoses, which were divided in intermediate (< 70% - 327) and severe (125). The correlation coefficients between the diameter of the stenosis (%DS) and FFR and the accuracy of VA of the angiography when assessing ischemia were determined. RESULTS: FFR could be obtained in 452 lesions (96%). Mean %DS and FFR were 56 ± 8% and 0.74 and 76 ± 6% and 0.48 for moderate and severe stenoses, respectively. Concordance between QCA and FFR was poor, especially in intermediate stenoses (Spearman's rho = - 0.33, p<0.0001). Visual assessment resulted in an accuracy of 57% and 96% in intermediate and severe lesions, respectively. CONCLUSION: Neither the visual assessment of an angiogram nor QCA can accurately predict the significance of most intermediate coronary stenoses, which emphasizes the importance of associating it to a functional evaluation of the coronary circulation, resulting in an adequate treatment of these stenoses.

Coronary angiography; angioplasty, transluminal, percutaneous; transluminal; stents; myocardial ischemia


FUNDAMENTO: A angiografia vem sendo utilizada como padrão de referência para definição de doença arterial coronariana (DAC), embora suas limitações sejam conhecidas. O valor da medida do fluxo fracionado de reserva do miocárdio (FFR) na avaliação da DAC está bem estabelecido. OBJETIVO: O objetivo deste estudo é avaliar a acurácia da angiografia em definir as lesões isquêmicas e sua correlação com o FFR. MÉTODOS: Duzentos e cinqüenta pacientes foram incluídos no estudo (471 vasos). Todas as estenoses > 50% pela estimativa visual da angiografia (EVA) foram avaliadas medindo-se o FFR. Se o FFR <0,75 a lesão foi tratada, se o FFR >0,75 a lesão não foi tratada. As lesões foram divididas em moderadas (<70% - 327) e graves (125) pela QCA. Foram determinados o coeficiente de correlação entre o grau de estenose (%DE), o FFR e a acurácia da EVA em definir se uma lesão era ou não isquêmica. RESULTADOS: Foi possível obter o FFR em 96% das lesões. %DE e FFR médios de 56±8% e 0,74 e 76±6% e 0,48 para as lesões moderadas e graves respectivamente. Notou-se pobre correlação entre o %DE e o FFR, especialmente nas lesões moderadas (Spearman rho = - 0.33, p<0,0001). A acurácia da EVA comparada com FFR foi de 57% e 96% nas lesões moderadas versus graves. CONCLUSÃO: A angiografia coronária não é adequada para avaliar a importância funcional das lesões coronarianas, sendo necessário associá-la a um método funcional capaz de fazê-lo, especialmente nas lesões moderadas.

Angioplastia coronária; angioplastia transluminal percutânea coronária; contenedores; isquemia miocárdica


ORIGINAL ARTICLE

ISanta Helena Hospital do Coração, Cabo Frio, RJ, Brazil

IIInstituto do Coração da Universidade de São Paulo, São Paulo, SP, Brazil

IIICatharina Hospital, Eindhoven, Holanda

Mailing Address

SUMMARY

BACKGROUND: The angiography has been used as a reference standard to define coronary artery disease (CAD), although its limitations are well-known. The significance of the myocardial fractional flow reserve (FFR) in the assessment of CAD is well established.

OBJECTIVE: The aim of this study was to evaluate the accuracy of angiography when defining ischemic lesions and its correlation with FFR.

METHODS: Two hundred and fifty consecutive patients (471 arteries) were included in this study. All stenoses > 50% at the angiography visual estimate (AVE) were assessed by FFR measurements. When FFR was < 0.75, stenting was performed; when FFR was > 0.75, no interventional treatment was carried out. Offline quantitative coronary angiography (QCA) was performed in all stenoses, which were divided in intermediate (< 70% - 327) and severe (125). The correlation coefficients between the diameter of the stenosis (%DS) and FFR and the accuracy of VA of the angiography when assessing ischemia were determined.

RESULTS: FFR could be obtained in 452 lesions (96%). Mean %DS and FFR were 56 ± 8% and 0.74 and 76 ± 6% and 0.48 for moderate and severe stenoses, respectively. Concordance between QCA and FFR was poor, especially in intermediate stenoses (Spearman's rho = - 0.33, p<0.0001). Visual assessment resulted in an accuracy of 57% and 96% in intermediate and severe lesions, respectively.

CONCLUSIONS: Neither the visual assessment of an angiogram nor QCA can accurately predict the significance of most intermediate coronary stenoses, which emphasizes the importance of associating it to a functional evaluation of the coronary circulation, resulting in an adequate treatment of these stenoses.

Keywords: Coronary angiography; angioplasty, transluminal, percutaneous; transluminal, stents, myocardial ischemia.

Introduction

It is well known that the presence of myocardial ischemia verified at the myocardial scintigraphy is one of the most important prognostic factors in patients with coronary artery disease (CAD)1,2. However, many percutaneous coronary interventions (PCI) are performed based solely on angiographic criteria, without previous assessment of the existence of ischemia3. Additionally, despite its unquestionable qualities, the angiography presents known limitations when estimating the real severity of coronary obstructions, particularly in cases with moderate stenosis4,5.

On the other hand, the significance of the fractional flow reserve (FFR) in defining myocardial ischemia has been largely established6-8. It is known that vessels that present FFR > 0.75 can be safely treated with conservative therapies, whereas a FFR <0.75 is a sign of myocardial ischemia and the patients, in these cases, could benefit from percutaneous or surgical revascularization procedures9-11.

The aim of this study was to assess, in all patients (and lesions) submitted to PCI at the Interventionist Cardiology Service of Santa Helena Hospital do Coracao within a certain period of time, the accuracy of the angiography visual estimate (AVE) and the quantitative coronary angiography (QAT) when identifying the lesions responsible for the myocardial ischemia, comparing their results with those obtained by FFR.

Methods

The present study included 250 patients referred for elective coronary angioplasty from October 2004 to April 2005. Patients with chronic coronary occlusion or angiographically significant disease in the left coronary trunk were excluded. All patients had undergone diagnostic coronary angiography two days to three weeks before the intervention.

Figure 1 shows the study design. Three independent cardiologists, blinded to the patients' symptoms, evaluated the angiographies of all patients selected for the angioplasty. They classified the coronary lesions in two categories, according to the AVE:


1) significant lesions at the AVE, of which treatment indication was angioplasty with or without stenting;

2) non-significant lesions at the AVE, of which treatment indication was not to treat. In case of lack of consensus regarding the visual impression of the cardiologists, the decision to treat or no to treat was based on the simple majority.

Cardiac catheterism and intracoronary pressure measurements

The catheterism was carried out via femoral artery, using guide catheters 6F or 7F without lateral orifices. Before the angiography, 10,000 IU of IV heparin and 0.5 mg of intracoronary nitroglycerin were administered. Subsequently, the intracoronary pressure measurements were carried out in all vessels with stenosis > 50% at the AVE, using a 0.014" guide wire (PressureWire® 4 Sensor, RADI Medical Systems, Uppsala, Sweden) positioned at the distal bed of each coronary to be analyzed, one at a time12. IV adenosine was administered through the sheath placed in the femoral vein at a dose of 140 µg/kg/min to induce maximum hyperemia. FFR was determined automatically as the ratio between the mean distal pressure of the coronary and the mean pressure of the aorta (measured by the guide catheter), during maximum hyperemia6. All the stenoses responsible for ischemia (FFR <0.75) were treated by percutaneous intervention, as long as technically possible. Stenoses of which FFR were > 0.75 were not submitted to PCI.

Quantitative coronary angiography (QCA) and lesion classification

The quantitative coronary angiography (QCA) was performed offline by choosing the angiographic projection in which the lesion showed to be more severe, using a software with an algorithm of automatic detection of arterial borders (CAAS II, Pie Medical Imaging, Maastricht, The Netherlands), as previously described13.

The coronary lesions were then classified in two groups:

I) Moderate lesions: between 40% and 70% by the QCA;

2) Severe lesions: > 70% by QCA.

Statistical analysis

All the variables were tested for normality by the Shapiro-Wilks and/or Kolmogorov-Smirnov tests. At the descriptive analysis, the numerical variables were presented as means±standard deviations (SD) and interquartiles and the categorical variables as numbers (n) and percentages (%). The Chi-square test and Fisher's exact test were used for the categorical variables; the non-paired Student's t test and Mann-Whitney test were used for continuous variables. The angiographic characteristics and the FFR were compared between the groups with moderate and severe lesions. Spearman correlation coefficient (rho) between the QCA and the FFR was calculated for both groups. The sensitivity, specificity, positive predictive value, negative predictive value and the accuracy of the AVE when defining whether a certain lesion was responsible for ischemia were also determined, using the FFR as the reference standard. The statistical analysis was carried out with the Stata SE 9.1 program (Stata Corporation, Houston, Texas). Values of p<0.05 were considered statistically significant and they were all two-tailed.

Results

During a period of seven consecutive months, 284 patients were admitted at our Service to undergo coronary angioplasty with or without stenting. Of these, 9 had acute myocardial infarction (AMI) and 25 presented chronic coronary occlusion and were excluded from the study. Thus, 250 patients were included in the study.

The clinical characteristics of these patients can be seen in Table 1. Most of the patients (70%) presented stable angina and multiarterial disease (uniarterial: 30%; biarterial: 43%; triarterial: 27%). After the analysis of the FFR, the distribution of patients with significant lesions in one, two, or three vessels was altered, as shown in Figure 2.


The FFR measurement was attained successfully in 452 (96%) analyzed lesions. It was not possible to measure the FFR in 19 stenoses, due to technical problems (extreme tortuosity, unsuccessful lesion-crossing with the guide wire or very distal lesion). The angioplasty with stenting was performed in 256 stenoses related to 193 patients, with 100% of success of the procedure in this group of lesions.

Angiography visual estimate versus FFR

There was complete agreement among the cardiologists in charge of reviewing the angiographies in relation to the treatment strategy per lesion in 65% of the stenoses and disagreement in 35% of them, between one of the reviewers and the other two.

The PCI was indicated in 350 lesions based on the angiographic criterion of visual estimate of the lesion. After the measurement of the FFR, it was verified that 30% of these stenoses (105) were not responsible for ischemia (FFR >0.75) and no interventionist treatment was performed. However, the reviewer cardiologists considered that 100 stenoses did not have functional significance and should be only followed and treated with medications. The FFR measurement showed that 40% of these lesions (41) were ischemic (FFR <0.75) and needed some type of intervention when technically possible.

The capacity of the AVE in detecting myocardial ischemia, using the FFR as the reference standard, resulted in high sensitivity (85.7%), but low specificity (36.7%), positive (70%) and negative (59.8%) predictive values. The accuracy of the AVE was 68% in the group of studied lesions. When only the moderate lesions were considered, the accuracy of the AVE was 57% versus 96% in severe lesions. The interpretation error regarding lesion severity in moderate lesions was in both directions, that is, apparently severe lesions that showed to be harmless and lesions with benign angiographic characteristics that showed to be ischemic.

QCA versus FFR

The angiographic characteristics of the moderate and severe lesions are shown in Table 2. An inverse correlation was observed between the degree of stenosis by QCA and the FFR (Figure 3), which was better in the severe lesions (rho = - 0.55; p<0.0001) then in the moderate ones (rho = - 0.33; p<0.0001). In the group of moderate lesions, the cutoff above which more than 90% of the lesions were ischemic was 64%; similarly, stenoses below 40% by QCA presented a low possibility of being responsible for ischemia (<10%).


In the present study, the pre-PCI minimum luminal diameter (MLD) was not a good parameter to infer ischemia. FFR values > or < 0.75 occurred in all MLD ranges.

Discussion

The results of the present study confirm the limitations of the angiography when allowing the precise identification of hemodynamically significant stenoses. This method showed to be imprecise to promote the identification of obstructions that disturb the coronary flow, especially in cases where the decrease in lumen diameter was defined as moderate, i.e., between 40% and 70% by the QCA.

Several studies have demonstrated that the treatment of patients with evidence of ischemia is beneficial and yields good mid- and long-term results; however, to revascularize based on anatomical criteria is debatable and does not seem to present any advantage in relation to the conservative treatment1,9-11. Considering the consensus of the American College of Cardiology/American Heart Association (ACC/AHA) to justify a PCI, it is necessary to prove the existence of ischemia14,15. Considering that, in many cases, the patients are referred to PCI with no objective evidence of ischemia3 and as the FFR is an effective and specific index per lesion to indicate whether a certain stenosis is responsible for the ischemia6-9, the present study suggests that many patients, especially the multiarterial ones, are referred to PCI without an adequate selection of the lesions to be treated, especially in the group of moderate lesions.

It is also known that the myocardial scintigraphy and other non-invasive methods to detect ischemia, although well-established, also present limitations. Lima et al16 carried out a study in which they assessed 143 patients with triarterial CAD documented by angiography, to evaluate whether the association of ventricular function assessment with perfusion through single photon emission computed tomography (SPECT) increases the detection in multiple vascular sites. They observed that only 46% of the patients with significant triarterial disease showed a "multivascular pattern" at the SPECT. In contrast, the FFR measured in the atherosclerotic vessels in the uniarterial as well as multiarterial disease provides the interventionist cardiologist precise functional and spatial information with an accuracy of more than 90% and can be evaluated at the same time of the coronary angiography, showing to be a cost- and time-saving measure for the patient and the health system6-9.

The incorporation of the physiological information to the diagnosis repertoire of the interventionist cardiologist can be very useful in decision-making during PCI, especially in moderate stenoses, which are the most often found in daily practice. The FFR has been validated in experimental models as well as in studies in humans, under several different clinical conditions in recent years8,17-19. It is a simple, reproducible6,7 and safe method as well as being independent from the hemodynamic state and suffer little influence of the microcirculation. Its correlation with the non-invasive methods such as myocardial scintigraphy, the dobutamine stress echo test and the stress test is very good and additionally, it has the advantage of being specific for each vessel and obstruction8,12.

The AVE as well as the QCA are limited methods when evaluating moderate lesions. Fischer et al4 assessed 83 moderate lesions (between 40% and 70%) and compared the angiography visual estimate and the QCA with the FFR in the detection of ischemic lesions. Their findings suggested that the AVE as well as the QCA were little effective when predicting the functional meaning of most of the moderate stenoses, especially those lesions < 60%.

These data were corroborated by the present study, which showed that moderate lesions at the angiography can induce to error, not only when the cardiologist indicates the need for revascularization in cases where there is no ischemia, but also in cases where patients with reduced myocardial perfusion do not receive the most adequate treatment. Sant'Anna et al20, using the FFR as a routine tool in all elective angioplasties during a certain period of time, showed that 32% of the coronary lesions and 48% of the patients would have received inadequate treatment if only the AVE result had been considered, emphasizing the usefulness of the FFR measurement as an auxiliary tool in decision-making during PCI.

There are several limitations to the present study: first, it is generally considered that the patient will be submitted the coronary angiography and later to the elective PCI after undergoing some type of non-invasive test, which did not occur in most cases of the present study. However, this is the routine in many services in Brazil and other parts of the world3 and our study aimed at reflecting the actual situation of the practice of PCI in our country. Second, the process of assessment of the coronary lesions was subjective, based on individual experiences, although it still reflects, with higher accuracy, what happens in the real world. Furthermore, the three reviewers were cardiologists with a vast experience in the field of coronary angiography. Third, the cutoff value of FFR to define ischemia was 0.75, a value that was validated based on several studies6-8, which, in turn, analyzed only selected populations of uniarterial, non-diabetic and non-revascularized patients.

The population of the present study was more heterogeneous and included diabetic patients, with previous infarction, some who had been revascularized and probably some cases of myocardial hypertrophy. It is possible that investigations aiming at the analysis of the FFR performance in these populations, whose characteristics are more similar to those in our study, will demonstrate that the FFR values related to the presence of myocardial ischemia are different from that used in the present study, which could alter the calculation of angiography accuracy. However, these data are not available yet and therefore, we adopted the cutoff of 0.75 as the one that allowed the discrimination of the cases with and without myocardial ischemia.

Conclusion

The present study showed that the coronary angiography has reduced diagnostic accuracy for the detection of ischemia in moderate lesions, clearly demonstrating the need to associate it to a functional method capable of correctly managing the treatment of these stenoses. However, angiographically demonstrated lesions (at the QCA) have high association with the presence of ischemia.

Potential Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Sources of Funding

There were no external funding sources for this study.

Study Association

This article is part of the thesis of Doctoral submitted by Fernando Mendes Sant´Anna, from Instituto do Coração-USP.

References

  • 1. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation. 1997; 95 (8): 2037-43.
  • 2. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004; 11 (2): 171-85.
  • 3. Topol EJ, Ellis SG, Cosgrove DM, Bates ER, Muller DW, Schork NJ, et al. Analysis of coronary angioplasty practice in the United States with an insurance-claims data base. Circulation. 1993; 87 (5): 1489-97.
  • 4. Fischer JJ, Samady H, Mcpherson JA, Sarembock I, Powers E, Gimple L, et al. Comparison between visual assessment and quantitative angiography versus fractional flow reserve for native coronary narrowings of moderate severity. Am J Cardiol. 2002; 90 (3): 210-5.
  • 5. Bartunek J, Sys SU, Heyndrickx GR, Pijls NH, De Bruyne B. Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort. J Am Coll Cardiol. 1995; 26 (2): 328-34.
  • 6. Pijls NH, Van Gelder B, Van Der Voort P, Peels K, Bracke FA, Bonnier HJ, et al. Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis ion myocardial blood flow. Circulation. 1995; 92 (11): 3183-93.
  • 7. De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation. 1995; 92 (1): 39-46.
  • 8. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek J, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996; 334 (26): 1703-8.
  • 9. Bech GJW, Pijls NH, De Bruyne B, de Muinck ED, Hoorntje JC, Escaned J, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis - a randomized trial. Circulation. 2001; 103 (24): 2928-34.
  • 10. Berger A, Botman KJ, MacCarthy PA, Wijns W, Bartunek J, Heyndrickx GR, et al. Long-term guided clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol. 2005; 46 (3): 438-42.
  • 11. Legalery P, Schiele F, Seronde MF, Meneveau N, Wei H, Didier K, et al. One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty. Eur Heart J. 2005; 26 (24): 2623-9.
  • 12. Pijls NHJ. Optimum guidance of complex PCI by coronary pressure measurement. Heart. 2004; 90 (9): 1085-93.
  • 13. Reiber JH, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation. 1985; 71 (2): 280-8.
  • 14. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006; 113 (7): e166-286.
  • 15. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005; 26 (8): 804-47.
  • 16. Lima RS, Watson DD, Goode AR, Siadaty MS, Ragosta M, Beller GA, et al. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three vessel coronary artery disease. J Am Coll Cardiol. 2003; 42: 64-70.
  • 17. De Bruyne B, Hersbach F, Pijls NH, Bartunek J, Bech GJ, Heyndrickx GR, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "normal" coronary angiography. Circulation. 2001; 104 (20): 2401-6.
  • 18. De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De Winter H, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation. 2001; 104 (2): 157-62.
  • 19. Chhatriwalla A, Ragosta M, Powers E, Sarembock A, Gimple L, Fischer J, et al. High left ventricular mass index does not limit the utility of fractional flow reserve for the physiologic assessment of lesion severity. J Invas Cardiol. 2006; 18 (11): 544-9.
  • 20. Sant'Anna FM, Silva EE, Batista LA, Ventura FM, Barrozo CA, Pijls NH. Influence of routine assessment of fractional flow reserve on decision making during coronary interventions. Am J Cardiol. 2007; 99 (4): 504-8.
  • What is the angiography error when defining myocardial ischemia during percutaneous coronary interventions?

    Fernando Mendes Sant'AnnaI; Expedito Ribeiro da SilvaII; Leonardo Alves BatistaI; Marcelo Bastos BritoI; Fábio Machado VenturaI; Haroldo Adans FerrazI; Leonardo BuczynskiI; Carlos Alberto Mussel BarrozoI; Nico PijlsIII
  • Publication Dates

    • Publication in this collection
      01 Oct 2008
    • Date of issue
      Sept 2008

    History

    • Received
      15 Oct 2007
    • Reviewed
      14 Jan 2008
    • Accepted
      22 Feb 2008
    Sociedade Brasileira de Cardiologia - SBC Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil, Fax: +55 21 3478-2770 - São Paulo - SP - Brazil
    E-mail: revista@cardiol.br